# US 2021/0180103 A1 · Production of sterols in modified yeast

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0180103 A1
- Document ID: US20210180103A1
- Status: Published application
- Kind: A1
- Application number: 16/065,274
- Filed: 2016-12-20
- Published: 2021-06-17
- Earliest claimed: 2015-12-23
- Assignees: Dsm IP Assets B.V.
- Applicants: Dsm IP Assets B.V.
- Inventors: Hans-Peter HOHMANN; Regina LEBER; Martin LEHMANN; Corinna ODAR; Barbara PETSCHACHER; Harald PICHLER; Birgit PLOIER
- Web page: https://patentgrep.com/patent/US20210180103A1

## CPC

- C12P 33/00: Preparation of steroids
- C12P 33/16: Acting at 17 position
- C12N 1/16: Yeasts; Culture media therefor
- C12N 9/001: {acting on the CH-CH group of donors (1.3)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention is related to production of a sterol mix in a modified yeast cell, wherein the amount of zymosterol present in said mix is dramatically reduced or abolished via modification of sterol acyltransferase activity within said yeast. The modified yeast cell can be used for production of vitamin D3 or derivatives and/or metabolites thereof.

## Claims

### Claim 1

A yeast cell in which ERG5 and ERG6 are inactivated, wherein the sterol acyltransferase isoform ARE2 activity has been reduced or abolished, said yeast cell being used for the production of a sterol mix comprising cholesta-5,7,24(25)-trienol and zymosterol, wherein the percentage of zymosterol within said sterol mix is about 10% or less based on the total amount of sterols produced by said yeast cell.

### Claim 2

A yeast cell in which ERG5 and ERG6 are inactivated, wherein the activity of endogenous ARE2 has been reduced or abolished, said yeast cell being used for the production of a sterol mix comprising cholesta-5,7,24(25)-trienol and zymosterol, wherein the percentage of cholesta-5,7,24(25)-trienol is about 75% or more based on the total amount of sterols produced by said yeast cell.

### Claim 3

A yeast cell in which ERG5 and ERG6 are inactivated, wherein the ARE2 activity has been reduced or abolished, said yeast cell being used for the production of a sterol mix comprising cholesta-5,7,24(25)-trienol and zymosterol, wherein the ratio between cholesta-5,7,24(25)-trienol and zymosterol present in the sterol mix is in the range of about 7 to about 1.

### Claim 4 (depends on 1)

A yeast cell according to claim 1, wherein the yeast cell expresses a heterologous enzyme selected from EC 1.3.1.72 having sterol Δ24-reductase activity, preferably wherein the heterologous enzyme is originated from plant or vertebrate, more preferably originated from human, pig, dog, mouse, rat, horse or Danio rerio.

### Claim 5 (depends on 1)

A yeast cell according to claim 1, wherein the ARE1 activity has been reduced or abolished.

### Claim 6 (depends on 1)

A yeast cell according to claim 1, wherein the ARE2 or ARE1 and ARE2 activity has been abolished.

### Claim 7

A process for decreasing the amount of zymosterol produced by a yeast cell by at least 4-times, said process comprising:
(a) providing a yeast cell, in which ERG5 and ERG6 are inactivated,
(b) abolishing or reducing the ARE2 activity within said yeast cell,
wherein the reduction is compared to a yeast cell wherein ARE2 is active.

### Claim 8 (depends on 1)

Use of a yeast cell according to claim 1 for production of sterols, preferably for the production of vitamin D3 precursors, more preferably for the production of 7-dehydrocholesterol (7-DHC).

### Claim 9

A process for the production of a sterol mix, preferably a vitamin D3-precursor, more preferably 7-DHC, in a yeast cell comprising:
(a) inactivation of ERG5 and ERG6,
(b) reducing or abolishing the activity of ARE2 or reducing or abolishing the activity of ARE1 and ARE2,
(c) expressing of a heterologous enzyme selected from EC 1.3.1.72 having sterol Δ24-reductase activity on lathosterol, zymosterol or trienol, preferably plant or vertebrate sterol Δ24-reductase, more preferably vertebrate sterol Δ24-reductase;
(d) cultivating said yeast cell under conditions suitable for sterol production;
wherein the amount of zymosterol present in the sterol mix is about 3% or less based on the total amount of sterols.

### Claim 10 (depends on 9)

A process according to claim 9, wherein the ratio between 7-DHC and zymosterol present in the sterol mix is in the range of at least about 87 to about 2.

### Claim 11 (depends on 1, 7, 8, 9, 10)

A yeast cell according to claim 1 or a process according to claims 7 to 10, wherein ARE 1 and/or ARE2 are endogenous sterol acyltransferases.
